We are live on ! Find out more
WAM

Wolverine Asset Management Portfolio holdings

AUM $10.4B
1-Year Est. Return 4.78%
This Fund
S&P 500
This Quarter Est. Return
+5%
1 Year Est. Return
+4.78%
3 Year Est. Return
+13.26%
5 Year Est. Return
+14.28%
10 Year Est. Return
+46.35%
AUM
$9.96B
AUM Growth
+$3.06B
Cap. Flow
-$3.35B
Cap. Flow %
-33.61%
Top 10 Hldgs %
26.66%
Holding
1,956
New
499
Increased
335
Reduced
399
Closed
432
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
1351
Acadia Pharmaceuticals
ACAD
$4.43B
$1K ﹤0.01%
+40
New +$1.92K
AGIO icon
1352
Agios Pharmaceuticals
AGIO
$1.79B
$1K ﹤0.01%
+37
New +$1.71K
ALNY icon
1353
Alnylam Pharmaceuticals
ALNY
$27.5B
$1K ﹤0.01%
+13
New +$1.75K
ASA
1354
ASA Gold and Precious Metals
ASA
$919M
$1K ﹤0.01%
+101
New +$1.46K
DXCM icon
1355
DexCom
DXCM
$31.5B
$1K ﹤0.01%
16
-1,428
-99% -$128K
EW icon
1356
Edwards Lifesciences
EW
$49.6B
$1K ﹤0.01%
+28
New +$1.99K
GDYN icon
1357
Grid Dynamics Holdings
GDYN
$559M
$1K ﹤0.01%
271
-429
-61% -$3.52K
H icon
1358
Hyatt Hotels
H
$16.4B
$1K ﹤0.01%
+31
New +$1.65K
IONS icon
1359
Ionis Pharmaceuticals
IONS
$8.6B
$1K ﹤0.01%
+32
New +$1.78K
NBIX icon
1360
Neurocrine Biosciences
NBIX
$16.8B
$1K ﹤0.01%
+15
New +$1.66K
OPK icon
1361
Opko Health
OPK
$985M
$1K ﹤0.01%
550
PODD icon
1362
Insulet
PODD
$11.5B
$1K ﹤0.01%
10
-678
-99% -$130K
PZZA icon
1363
Papa John's
PZZA
$984M
$1K ﹤0.01%
19
-2,244
-99% -$167K
SPXU icon
1364
CALL
ProShares UltraPro Short S&P 500
SPXU
$406M
$1K ﹤0.01%
1
SRPT icon
1365
Sarepta Therapeutics
SRPT
$1.57B
$1K ﹤0.01%
+11
New +$1.5K
UTHR icon
1366
United Therapeutics
UTHR
$25.8B
$1K ﹤0.01%
+16
New +$1.8K
WING icon
1367
Wingstop
WING
$3.53B
$1K ﹤0.01%
+11
New +$1.28K
XFLT
1368
XAI Floating Rate & Alternative Income Trust
XFLT
$286M
$1K ﹤0.01%
+52
New +$1.29K
NTCO
1369
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$1K ﹤0.01%
+120
New +$1.57K
VNTR
1370
PUT
DELISTED
Venator Materials PLC
VNTR
$1K ﹤0.01%
1,000
GBT
1371
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1K ﹤0.01%
+31
New +$2.13K
STRDW
1372
DELISTED
Sitio Royalties Corp. Warrant
STRDW
$1K ﹤0.01%
17,301
XLRN
1373
DELISTED
Acceleron Pharma
XLRN
$1K ﹤0.01%
+17
New +$1.64K
ALXN
1374
DELISTED
Alexion Pharmaceuticals
ALXN
$1K ﹤0.01%
+17
New +$1.8K
AIG.WS
1375
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
1,100
-161,111
-99% -$187K

Similar funds

Wolverine Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Wolverine Asset Management held 1,956 positions worth $9.96B, up 44% from $6.89B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Wolverine Asset Management withdrew a net $3.35B in Q2 2020, closing 432 positions and reducing 399 holdings. Its most notable exit was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A, an estimated $20.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 2.8% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Wolverine Asset Management opened a new position in Hycroft Mining Holding Corp worth $17.9M.

  • Wolverine Asset Management's largest Q2 2020 buy was Hycroft Mining Holding Corp: 225,049 shares worth $17.9M.
  • Wolverine Asset Management added most to Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q2 2020, an estimated $27.1M increase.
  • Wolverine Asset Management's biggest Q2 2020 reduction was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $32.5M.
  • Wolverine Asset Management fully exited Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $20.2M.
  • Wolverine Asset Management's ten largest holdings make up 27% of its $9.96B portfolio in Q2 2020.
  • Wolverine Asset Management opened 499 new positions and closed 432 in Q2 2020.
  • Wolverine Asset Management's portfolio value rose 44% quarter-over-quarter to $9.96B.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.